NCT06991556 2026-04-16
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Novartis
Phase 2 Recruiting
Clinical Trials
7 trialsNCT05901649 2026-04-13
ArtemisPRO
Janssen-Cilag Ltd.
Active not recruiting
NCT06874114 2026-04-13
RE-ENGAGE
Bayer
Active not recruiting
NCT00309985 2025-12-11
CHAARTED
Eastern Cooperative Oncology Group
Phase 3 Completed
NCT02799602 2025-12-04
ARASENS
Bayer
Phase 3 Completed
NCT07031258 2025-06-22
Evaluation of the Efficacy of Darolutamide Triplet Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer
Nanfang Hospital, Southern Medical University
Not yet recruiting
NCT06498921 2024-10-24
BELBEQA
Bayer
Completed